The possible therapeutic role of advanced glycation end-product inhibitors in ischemic stroke
The advanced glycation end-products (AGEs) are toxic molecules result from non-enzymatic interactions of sugar with lipids or proteins. AGEs promote the generation of reactive oxygen species that induce the release of pro-inflammatory cytokines, and alter the intracellular signaling leading to progr...
Saved in:
Main Authors: | Nada H. Aljarba, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Mustafa M. Shokr, Marios Papadakis, Athanasios Alexiou, Mubarak Alruwaili, Mohammed Alrouji, Mohammed S. Alshammari, Gaber El-Saber Batiha |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Brain Research Bulletin |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0361923025000486 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective
by: Bshra A. Alsfouk, et al.
Published: (2025-02-01) -
Advanced glycation end products and risk of mortality in patients with cirrhosis: a prospective cohort study
by: Mohsen Shaygan Tabar, et al.
Published: (2025-02-01) -
Role of microRNA in the risk stratification of ischemic strokes
by: Hosam M. Al-Jehani, et al.
Published: (2025-02-01) -
Recurrent “transient ischemic attacks” caused by pulmonary arteriovenous malformation
by: Jorrit B.A. Welling, et al.
Published: (2025-01-01) -
Efficacy of Intravenous Tenecteplase Bridge Thrombectomy for Recurrent Ischemic Stroke Within 3 Months: A Case Report
by: Liu C, et al.
Published: (2025-02-01)